Patricia Oto

Patti has 25+ years of executive leadership experience with regulatory and quality oversight. Prior to joining CAGE Bio, Patti served as the Senior Vice President of Regulatory Affairs and Quality Assurance at Chrono Therapeutics. She has held positions at Incline Therapeutics (acquired by The Medicines Company), Onyx Pharmaceuticals (Amgen), Corgentech (Anesiva), Coulter (Corixa, GlaxoSmithKline), Genentech (Roche), and Syntex. Patti has worked on global regulatory submissions in several therapeutic areas.